• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由S100A9介导的中性粒细胞与内皮细胞相互作用促进肺动脉高压时的肺血管重塑。

Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.

作者信息

Guo Yu, Gao Zhenqiang, Zhang Ruoyang, Long Huanyu, Zhang Muzhi, Liu Lin, An Zhe, Shi Yuezhe, Cui Ye, Jia Yufeng, Wang Lei, Sun Ying, Liu Jie, Wang Wei

机构信息

Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.

Department of Respiratory Medicine, Capital Medical University, Beijing, 100069, China.

出版信息

Adv Sci (Weinh). 2025 Aug;12(31):e04397. doi: 10.1002/advs.202504397. Epub 2025 Jun 10.

DOI:10.1002/advs.202504397
PMID:40492585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12376707/
Abstract

Pulmonary hypertension (PH) is a severe disease characterized by pulmonary vascular remodeling in which various immune cells play a critical role in vascular remodeling, although the details are still vague. Furthermore, current clinical treatments primarily focus on pulmonary vasodilation, but do not fundamentally address vascular remodeling itself. Here, first significant changes in neutrophils during the development of PH are demonstrated and show that neutrophil depletion can effectively attenuate disease progression. Moreover, the data show that neutrophil-derived S100A9 is the key mediator to promote vascular remodeling, while both knockout and inhibition of S100A9 can prevent PH. In a co-culture system of neutrophils and endothelial cells (ECs), hypoxic stimulation leads to increased S100A9 secretion by neutrophils, which activates the RAGE/PI3K/AKT pathway and causes dysfunction of ECs. These findings suggest that neutrophil-derived S100A9 mediated neutrophil-EC crosstalk plays an important role in pulmonary vascular remodeling, providing a promising strategy for treatment of PH.

摘要

肺动脉高压(PH)是一种严重疾病,其特征为肺血管重塑,尽管具体细节仍不明确,但多种免疫细胞在血管重塑中发挥关键作用。此外,目前的临床治疗主要集中在肺血管舒张上,并未从根本上解决血管重塑本身的问题。在此,首次证明了PH发展过程中中性粒细胞的显著变化,并表明中性粒细胞减少可有效减缓疾病进展。此外,数据显示中性粒细胞衍生的S100A9是促进血管重塑的关键介质,而敲除和抑制S100A9均可预防PH。在中性粒细胞与内皮细胞(ECs)的共培养系统中,缺氧刺激导致中性粒细胞分泌的S100A9增加,激活RAGE/PI3K/AKT通路并导致ECs功能障碍。这些发现表明,中性粒细胞衍生的S100A9介导的中性粒细胞与ECs的相互作用在肺血管重塑中起重要作用,为PH的治疗提供了一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/819fb97bf9b0/ADVS-12-e04397-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/88de56ef10c4/ADVS-12-e04397-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/b6a8759e3dc7/ADVS-12-e04397-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/a995c4059f1c/ADVS-12-e04397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/94abe40dc92c/ADVS-12-e04397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/067fbec07d74/ADVS-12-e04397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/a7776ac2920a/ADVS-12-e04397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/643482b3226a/ADVS-12-e04397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/819fb97bf9b0/ADVS-12-e04397-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/88de56ef10c4/ADVS-12-e04397-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/b6a8759e3dc7/ADVS-12-e04397-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/a995c4059f1c/ADVS-12-e04397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/94abe40dc92c/ADVS-12-e04397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/067fbec07d74/ADVS-12-e04397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/a7776ac2920a/ADVS-12-e04397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/643482b3226a/ADVS-12-e04397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/12376707/819fb97bf9b0/ADVS-12-e04397-g009.jpg

相似文献

1
Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.由S100A9介导的中性粒细胞与内皮细胞相互作用促进肺动脉高压时的肺血管重塑。
Adv Sci (Weinh). 2025 Aug;12(31):e04397. doi: 10.1002/advs.202504397. Epub 2025 Jun 10.
2
PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension.PAI-1 缺乏导致肺血管平滑肌重塑和肺动脉高压。
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L319-L326. doi: 10.1152/ajplung.00110.2024. Epub 2024 Jun 11.
3
Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.新生儿高氧诱导肺动脉高压中的内皮到间充质转化。
J Pathol. 2020 Dec;252(4):411-422. doi: 10.1002/path.5534. Epub 2020 Oct 6.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.单细胞和空间转录组学鉴定出控制肺动脉高压中内皮糖酵解和动脉编程的脂肪酸结合蛋白
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173.
6
Single-cell RNA sequencing reveals that myeloid S100A8/A9 is a novel regulator of the transition from adaptive hypertrophy to heart failure after pressure overload.单细胞RNA测序显示,髓系S100A8/A9是压力超负荷后从适应性肥大转变为心力衰竭的新型调节因子。
Theranostics. 2025 Jul 28;15(16):8587-8608. doi: 10.7150/thno.118369. eCollection 2025.
7
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension.单核RNA测序揭示肺泡巨噬细胞是肥胖型射血分数保留的心力衰竭相关肺动脉高压中内皮损伤的驱动因素。
Cardiovasc Diabetol. 2025 Jul 3;24(1):268. doi: 10.1186/s12933-025-02772-y.
8
High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.高剪切应力降低ERG导致内皮-间充质转化和肺动脉高压。
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):218-237. doi: 10.1161/ATVBAHA.124.321092. Epub 2024 Dec 26.
9
Role of inflammation in endothelial responses in Pulmonary Hypertension.炎症在肺动脉高压内皮反应中的作用。
Biomed Pharmacother. 2025 Jul;188:118206. doi: 10.1016/j.biopha.2025.118206. Epub 2025 May 28.
10
The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH.先天性膈疝的硝芬/双二胺小鼠模型具有与人类先天性膈疝一致的肺动脉高压血管表型。
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L48-L60. doi: 10.1152/ajplung.00233.2024. Epub 2025 May 30.

本文引用的文献

1
Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.内皮细胞 PH 酶 2 缺乏通过 AKT 激活和 AIP1 缺失诱导细胞凋亡抵抗和炎症,与 HIF2α 无关。
Am J Physiol Lung Cell Mol Physiol. 2024 Oct 1;327(4):L503-L519. doi: 10.1152/ajplung.00077.2024. Epub 2024 Aug 19.
2
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.肺动脉高压的免疫治疗:从发病机制到临床管理。
Int J Mol Sci. 2024 Aug 1;25(15):8427. doi: 10.3390/ijms25158427.
3
S100A8/A9 neutrophils induce mitochondrial dysfunction and PANoptosis in endothelial cells via mitochondrial complex I deficiency during sepsis.
S100A8/A9 中性粒细胞通过脓毒症期间线粒体复合物 I 缺乏诱导内皮细胞线粒体功能障碍和 PANoptosis。
Cell Death Dis. 2024 Jun 28;15(6):462. doi: 10.1038/s41419-024-06849-6.
4
Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.内皮细胞异质性在自噬反应中的作用驱动肺动脉高压中小血管的肌化。
Circulation. 2024 Aug 6;150(6):466-487. doi: 10.1161/CIRCULATIONAHA.124.068726. Epub 2024 Jun 14.
5
PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling.PD-1/PD-L1 在低氧诱导的肺血管重构中发挥保护作用。
Hypertension. 2024 Aug;81(8):1822-1836. doi: 10.1161/HYPERTENSIONAHA.123.22393. Epub 2024 Jun 10.
6
Advances in the study of S100A9 in cardiovascular diseases.S100A9 在心血管疾病中的研究进展。
Cell Prolif. 2024 Aug;57(8):e13636. doi: 10.1111/cpr.13636. Epub 2024 Mar 19.
7
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs.抗肺动脉高压药物对前列环素受体的分子识别与激活。
Sci Adv. 2024 Feb 9;10(6):eadk5184. doi: 10.1126/sciadv.adk5184.
8
Pulmonary hypertension.肺动脉高压
Nat Rev Dis Primers. 2024 Jan 4;10(1):1. doi: 10.1038/s41572-023-00486-7.
9
Inhibition of the HMGB1/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress.抑制 HMGB1/RAGE 轴通过抑制炎症和氧化应激来防止顺铂诱导的耳毒性。
Int J Biol Sci. 2024 Jan 1;20(2):784-800. doi: 10.7150/ijbs.82003. eCollection 2024.
10
Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity.S100A8、S100A9和S100A12在感染、炎症和免疫中的作用。
Immunology. 2024 Mar;171(3):365-376. doi: 10.1111/imm.13722. Epub 2023 Nov 27.